| AgRP | agouti-related peptide |
| AMPK | AMP-activated protein kinase |
| C/EBPα | CCAAT/enhancer-binding protein alpha |
| CB1 | cannabinoid type 1 receptors |
| CCK | cholecystokinin |
| CNS | central nervous system |
| EGCG | epigallocatechin gallate |
| EMEA | European Agency for the Evaluation of Medicinal Products |
| FDA | Food and Drug Administration |
| GLP-1 | glucagon-like peptide 1 |
| HDL | high density lipoproteins |
| HeLa | human cervical cancer cells |
| Hep-G2 | hepatocellular carcinoma cell line |
| HL-60 | promyelocytic leukemia cells |
| HT1080 | fibrosarcoma cell line |
| ICD | International Classification of Diseases |
| LDL | low density lipoproteins |
| MAPK | mitogen-activated protein kinase |
| MDA-MB-453 | breast cancer cell line |
| NPY | neuropeptide Y |
| PL | pancreatic lipase |
| PPARγ | peroxisome proliferator-activated receptor γ |
| PYY | peptide YY |
| SREBP-1c | sterol regulatory element-binding protein-1c |
| VLDL | very low density lipoproteins |
| WHO | World Health Organization |